A review of the United States clinical experience of the fluoropyrimidine, ftorafur (NSC-148958).
D000284:Administration, Oral; D004305:Dose-Response Relationship, Drug; D004341:Drug Evaluation; D004359:Drug Therapy, Combination; D005472:Fluorouracil / Q000031:analogs & derivatives*; D006801:Humans; D007275:Injections, Intravenous; D009369:Neoplasms / Q000188:drug therapy*; D005641:Tegafur / Q000008:administration & dosage / Q000134:cerebrospinal fluid / Q000627:therapeutic use*
D005641:Tegafur; D005472:Fluorouracil